Human recombinant tissue factor, platelet-rich plasma, and tetracycline induce a high-quality human bone graft: A 5-year survey

International Journal of Oral and Maxillofacial Implants

Volumn 18, Issue 3, 2003, Pages 411-416

  Philippart, Pierre ^a   Brasseur, Michèle ^a   Hoyaux, Daphne ^b   Pochet, Roland ^b  

^a IRIS   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Autologous bone graft; Dental implants; Histology; Platelet rich plasma; Sinus augmentation; Tissue factor

Indexed keywords

RECOMBINANT THROMBOPLASTIN; TETRACYCLINE; ANTIINFECTIVE AGENT; RECOMBINANT PROTEIN; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD SAMPLING; BONE BIOPSY; BONE GRAFT; BONE REGENERATION; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; EDENTULOUSNESS; EXTRACTION; FEMALE; HEALTH SURVEY; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAW DISEASE; MALE; MAXILLARY SINUS; OSTEOCYTE; POSTOPERATIVE CARE; SURGICAL TECHNIQUE; THROMBOCYTE RICH PLASMA; TOOTH IMPLANTATION; VASCULARIZATION; BONE TRANSPLANTATION; DRUG EFFECT; FOLLOW UP; MAXILLA; METHODOLOGY; MIDDLE AGED; ORAL SURGERY; OSTEOBLAST; PATHOLOGY; THROMBOCYTE TRANSFUSION; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; ALVEOLAR RIDGE AUGMENTATION; ANTI-BACTERIAL AGENTS; BONE REGENERATION; BONE TRANSPLANTATION; CONNECTIVE TISSUE; DENTAL IMPLANTATION, ENDOSSEOUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MAXILLA; MAXILLARY SINUS; MIDDLE AGED; OSTEOBLASTS; OSTEOCYTES; PLATELET TRANSFUSION; RECOMBINANT PROTEINS; TETRACYCLINE; THROMBOPLASTIN; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 0042420611     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. McAllister BS, Margolin MK, Cogan AG, Buck D, Hollinger JO, Lynch SE. Eighteen-month radiographic and histologic evaluation of sinus grafting with anorganic bovine bone in the chimpanzee. Int J Oral Maxillofac Implants 1999;14:361-368.
2. Wheeler SL, Holmes RE, Calhoun CJ. Six-year clinical and histologic study of sinus-lift grafts. Int J Oral Maxillofac Implants 1996;11:26-34.
3. Jensen OT. Combined sinus grafting and Le Fort I procedures. In: Jensen OT (ed). The Sinus Bone Graft. Chicago: Quintessence, 1999:198-199.
4. Fugazzotto PA, Vlassis J. Long-term success of sinus augmentation using various surgical approaches and grafting materials. Int J Oral Maxillofac Implants 1998;13:52-58.
5. van den Bergh JPA, ten Bruggenkate CM, Krekeler G, Tuinzing DB. Maxillary sinus floor elevation and grafting with human demineralized freeze dried bone Clin Oral Implants Res 2000;11:487-493.
6. Cordioli G, Mazzocco C, Schepers E, Brugnolo E, Majzoub Z. Maxillary sinus floor augmentation using bioactive glass granules and autogenous bone with simultaneous implant placement. Clin Oral Implants Res 2001;12:270-278.
7. Marx RE, Carlson ER, Schimmele SR, Eichstaedt RM, Strauss JE, Georgeff K. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol 1998;85:638-646.
8. Slater M, Patava J, Kingham K. Involvement of platelets in stimulating osteogenic activity. J Orthop Res 1995;13:655-663.
9. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
10. Whitman DH, Berry RL. A technique for improving the handling of particulate cancellous bone and marrow grafts using platelet gel. J Oral Maxillofac Surg 1998;56:1217-1218.
11. Marchac D, Sandor G. Face lifts and sprayed fibrin glue: An outcome analysis of 200 patients. Br J Plastic Surg 1994;47:306-309.
12. Klapisz-Wolikow M, Saffar JL. Minocycline effects on activation phases of bone remodeling [abstract 1926]. J Dent Res 1992;71 (spec issue):756.
13. Gabler WL, Creamer HR. Suppression of human neutrophil functions by tetracyclines. J Periodont Res 1991;26:52-58.
14. Nemerson Y. Tissue factor and hemostasis. Blood 1988;71:1-8.
15. Bach R. Initiation of coagulation by tissue factor. CRC Crit Rev Biochem 1988;23:339-368
16. Krishnaswamy S. The interaction of human factor VIIa with tissue factor. J Biol Chem 1992;267(33):24696-24706.
17. Martin DMA, Boys CWG, Ruf W. Tissue factor: Molecular recognition and cofactor function. FASEB J 1995;9:852-859.
18. Lawson JH, Mann KG. Cooperative activation of human factor IX by the human extrinsic pathway of blood coagulation. J Biol Chem 1991;266:11317-11327.
19. Nemerson Y, Gentry R. An ordered addition, essential activation model of the tissue factor pathway of coagulation: Evidence for a conformotional cage. Biochemistry 1986;25:4022-4033.
20. Edgington TS, Dickinson CD, Ruf W. The structural basis of function of TF VIIa complex in the cellular initiation of coagulation. Thromb Haemost 1997;78:401-405.
21. Morrisey JH. Tissue factor: An enzyme cofactor and true receptor. Thromb Haemost 2001;86:66-74.
22. Siegbahn A, Johnell M, Rorsman C, Ezban M, Heldin CH, Ronnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB -stimulated chemotaxis. Blood 2000;96:3452-3458.
23. Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 1999;94:3413-3420.
24. Ollivier V, Bentolila S, Chabbat J, Hakim J, De Prost D. Tissue factor and vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood 1998;91:2698-2703.
25. Klein RM Jr, Wolfe SA. Complications associated with the harvesting of cranial bone grafts. Plast Reconstr Surg 1995;95:5-13.
26. El-Hakim IE. The effect of fibrin stabilizing factor (F.XIII) on healing of bone defects in normal and uncontrolled diabetic rats. Int J Oral Maxillofac Surg 1999;28:304-308.
27. Dhall TZ, Shah GA, Ferguson IA. Fibrin network structure: Modification by platelets. Thromb Haemost 1983;49:42-46.
28. Tawes RL, Sydorak GR, DuVall TB. Autologous fibrin glue: The last step in operative hemostasis. Am J Surg 1994;168:120-122.
29. Cawood JF, Howell RA. A classification of the edentulous jaws. Int J Oral Maxillofac Surg 1988;17:232-236.
30. Utz JA, Lull RJ, Galvin EG. Asymptomatic total hip prosthesis; Natural history determined using Tc-99m MDP bone scans. Radiology 1986;161:509-512.
31. Chisin R, Gazit D, Ulmansky M, Laron A, Atlan H, Sela J. 99mTc-MDP uptake and histology changes during rat bone marrow regeneration. Int J Rad Appl Instrum B 1988;15:469-476.
32. D'Addabbo A, Rubini G, Mele M, Lauriero F. A new method for assessing 99Tcm-MDP bone uptake from a bone scan image: Quantitative measurement of radioactivity in global skeletal regions of interest. Nucl Med Commun 1992;13:55-60.
33. McCracken M, Zinn K, Lemons JE, Thompson JA, Feldman D. Radioimaging of implants in rats using Tc-99m-MDP. Clin Oral Implants Res 2001;12:372-378.
34. Pierce GF, Tarpley J, Yanagihain D. PDGF-BB, TGF-B1 and basicFGF in dermal wound healing: Neo-vessel and matrix formation and cessation of repair. Am J Pathol 1992;140:1375-1388.
35. Pierce GF, Mustoe TA, Altrock BW, Deuel TF, Thomason A. Role of platelet-derived growth factor in wound healing. J Cell Biochem 1991;45:319-326.
36. Rompen EH, Nusgens B, Lapiere CM. In vitro modulation of osteoblast attachment by minocycline HCl [abstract]. J Parodont Implant Orale 1994;1:50.
37. Ohishi K, Fujita N, Morinaga Y, Tsuruo T. H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption. Clin Exp Metastasis 1995;13:287-295.